The predictive and prognostic value of serum CA125 kinetics and CA125 nadir during paclitaxel/platinum based chemotherapy (QT) in patients with advanced ovarian carcinoma (OC)

被引：0
|
作者：
Tibau, A. [1 ]
Ojeda, M. B. [1 ]
Nadal, R. M. [2 ]
Gallardo, A. [1 ]
Perez Altozano, J. [1 ]
Sala, N. [1 ]
Mazarico, J. M. [1 ]
Boguna, I. [1 ]
Artigas, V. [1 ]
Barnadas, A. [1 ]
机构：
[1] Hosp Santa Creu & Sant Pau, Barcelona, Spain
[2] Hosp del Mar, Barcelona, Spain
来源：
EJC SUPPLEMENTS | 2009年 / 7卷 / 02期
关键词：
D O I：
10.1016/S1359-6349(09)71548-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：457 / 457
页数：1
相关论文
共 50 条
  • [21] Clinical (WHO) and serum tumor marker (CA125) response to platinum based chemotherapy after treatment with paclitaxel in patients with ovarian cancer (OVCA)
    Vermorken, JB
    Huijskes, RVHP
    Hoekman, K
    Burger, CW
    Verheijen, RHM
    Heitbrink, MA
    Pinedo, HM
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 517 - 517
  • [22] Diagnostic value of CA125 as a predictor of recurrence in advanced ovarian cancer
    Song, M. J.
    Lee, S. H.
    Choi, M. R.
    Son, H. J.
    Lee, C. W.
    Yoon, J. H.
    Park, Y. G.
    Hur, S. Y.
    Ryu, K. S.
    Lee, J. M.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2013, 34 (02) : 148 - 151
  • [23] The role of extended chemotherapy in patients with advanced ovarian cancer with high posttreatment serum CA125 levels
    Kang, S.
    Kim, T.
    Seo, S.
    Kim, B.
    Bae, D.
    Park, S.
    GYNECOLOGIC ONCOLOGY, 2010, 116 (03) : S102 - S102
  • [24] CA125 regression during neoadjuvant chemotherapy as an independent prognostic factor for survival in patients with advanced ovarian serous adenocarcinoma
    Tate, S
    Hirai, Y
    Takeshima, N
    Hasumi, K
    GYNECOLOGIC ONCOLOGY, 2005, 96 (01) : 143 - 149
  • [25] Evaluation of prognostic value of CA125 serum levels in ICSI outcome
    Sohrabvand, F
    Bakhtiary, M
    Esfahani, F
    Jafarabadi, M
    RESEARCH PAPERS IN FERTILITY AND REPRODUCTIVE MEDICINE, 2004, 1271 : 81 - 84
  • [26] CA125 expression pattern, prognosis and correlation with serum CA125 in ovarian tumor patients - From The Danish "MALOVA" Ovarian Cancer Study
    Hogdall, Estrid V. S.
    Christensen, Lise
    Kjaer, Susanne K.
    Blaakaer, Jan
    Kjaerbye-Thygesen, Anette
    Gayther, Simon
    Jacobs, Ian J.
    Hogdall, Claus K.
    GYNECOLOGIC ONCOLOGY, 2007, 104 (03) : 508 - 515
  • [27] THE DIAGNOSTIC AND PROGNOSTIC VALUE OF HE4 AND CA125 IN OVARIAN CANCER PATIENTS
    Korse, Catharina M.
    Bonfrer, J. M. G.
    van Beurden, M.
    TUMOR BIOLOGY, 2010, 31 : S111 - S111
  • [28] PREDICTIVE VALUE OF THE COMBINATION OF SERUM MARKERS, CA125, CASA AND TPS IN OVARIAN-CANCER
    DEVINE, PL
    MCGUCKIN, MA
    QUIN, RJ
    WARD, BG
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1995, 5 (03) : 170 - 178
  • [29] A CA125 SCORE AS A PROGNOSTIC INDEX IN PATIENTS WITH OVARIAN-CANCER
    ROSEN, A
    SEVELDA, P
    KLEIN, M
    SPONA, J
    BECK, A
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 1990, 247 (03) : 125 - 129
  • [30] THE CLINICAL-VALUE OF SERUM CA125 LEVELS IN OVARIAN-CANCER PATIENTS RECEIVING PLATINUM THERAPY
    FISH, RG
    SHELLEY, MD
    MAUGHAN, T
    ROCKER, I
    ADAMS, M
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1987, 23 (06): : 831 - 835
12345